Sign in
4

Changes in Ownership

Ocugen, Inc. Filed Acc 0000899243-18-026060

Options or other derivatives

  • Chief Medical Officer acquired 200,000 shares (grant or award)
  • Chief Medical Officer returned 200,000 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Kelley Lynne E · Chief Medical Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2018-10-01 Returned to the company : show line 1 in the form Employee Stock Option (Right to Buy) −200,000 0 D
2018-10-01 Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) +200,000 200,000 D
Loading xslF345X03/doc4.xml…